Martina Vidláková's reply arrived without fanfare, a few paragraphs of institutional Czech precision that nonetheless cut to the bone of this investigation. Asked about differential outcomes for international students at Charles University's First Faculty of Medicine, the National Accreditation Bureau for Higher Education, the body the Czech Republic tasks with evaluating its universities, wrote that “the primary responsibility for quality of higher education lies with the higher education institutions” and that the NAB does not “collect or systematically monitor” the kind of nationality-disaggregated outcome data this column has been seeking. A second communication from the same bureau's office called the questions put to it “rather vague and general” and asked for specificity before any further comment could be offered.
Read those two replies together and the architecture of the problem stands exposed, not malice, not conspiracy, but a clean institutional gap. The accreditor defers to the institution. The institution's press office did not respond to requests for comment. Between deference and silence, roughly 800 international students enrolled in Charles University's six-year English-medium General Medicine programme, paying €24,250 a year in tuition, self-funded, self-selected, largely South and Southeast Asian, move through a system that generates no publicly available nationality-disaggregated data on progression rates, examination outcomes, or attrition. The question this column has framed as open, whether these students face differential outcomes compared to their Czech-language peers, remains open precisely because the data to answer it does not exist in any public form. That absence is itself a finding.
The Funnel That Produces the Exodus
To understand why any of this matters to India, return to the numbers that frame the domestic emergency. NTA figures show NEET-UG applicants climbed from roughly 8 lakh in 2016 to a peak of 24.1 lakh in 2024, easing marginally to 22.8 lakh in 2025. Against that demand, NMC and MoHFW data placed before Parliament show India added seats at speed, from 51,348 MBBS seats across 387 colleges in 2013-14 to roughly 1.23 lakh seats across 808 colleges in 2025-26. The arithmetic remains brutal: for every MBBS seat, nearly nineteen applicants sit the exam. At government colleges, the course costs approximately ₹3 lakh total; at private and NRI-quota institutions, the figure can reach ₹1 crore. The middle class that cannot clear the cutoff for a government seat and cannot afford a private one looks west, east, anywhere.
Prime Minister Modi put the aggregate on record on Independence Day 2024: roughly 25,000 Indian students leave for medical education abroad each year. Prague is one node in that dispersal. The First Faculty of Medicine at Charles University ranks among the more reputable such nodes, a centuries-old institution, an English-language programme with genuine academic standing. That is precisely why the outcome question matters. If even a well-regarded programme produces no trackable data on how its self-paying international cohort performs relative to domestic students, the Indian family writing the cheque is making a €145,500 decision, at minimum, in an informational void.
FMGE as the Reckoning
That void has a denominator in India. The Foreign Medical Graduate Examination, administered by NBEMS, is the filter every foreign-trained Indian doctor must clear to practise at home. In June 2025, 6,707 of 36,034 candidates passed, a rate of 18.6 percent. Across years, the range has held between roughly 10 and 25 percent. These are not anonymous statistics. Each number in the denominator is a family that spent years of savings, a young person who spent years of effort, and a healthcare system that needed both. The FMGE is not a rigged gate; it tests the same clinical and theoretical competencies the domestic system demands. But an 18.6 percent pass rate, sustained across years and cohorts, signals that the preparation these students received, somewhere, in some combination of selection, instruction, and support, was inadequate for the standard India sets.
Charles University is not uniquely implicated in that aggregate. Dozens of institutions across Eastern Europe, Central Asia, and the Caribbean feed into the FMGE pool. But Charles University is the institution under examination here, and the absence of any published data on how its Indian and international graduates perform on licensing examinations in their home countries means neither the university, nor Indian regulators, nor prospective students can assess the match between what is taught and what is required.
A System Under Strain, From Two Directions
On 25 July 2026, Union Education Minister Dharmendra Pradhan resigned as nationwide student protests over examination-paper leaks and NTA integrity failures reached a point the government could not manage with reappointments and committees. The Prague question and the Delhi question are not causally linked, the minister's resignation had nothing to do with overseas medical education. But they are diagnostically linked. Both are symptoms of a system stretched between demand it cannot meet at home and oversight it cannot exercise abroad. When the domestic examination architecture loses credibility, the pressure on the exit valve, the 25,000 who leave each year, only increases. And when the destinations those students choose operate without nationality-disaggregated outcome monitoring, the Indian state has no intelligence with which to protect them or advise them.
The Czech accreditation bureau's candour is, in its way, useful. Vidláková's office did not claim the system was adequate; it described how the system is structured. Primary responsibility sits with the institution. The institution, in this investigation, has not engaged. That is not grounds to assert that Charles University treats its international students differently, the data to prove or disprove that claim does not exist in the public domain. It is grounds to say that the question cannot be answered, and that the inability to answer it is a governance failure shared between Prague and New Delhi.
What India Must Now Demand
The NMC holds the statutory authority to condition recognition of foreign medical qualifications on data disclosure. It could, without new legislation, require that any foreign institution whose graduates sit the FMGE publish annual cohort-level outcome data, progression rates, attrition, final-year examination results, disaggregated by nationality. That is not an aggressive demand; it is the minimum information standard India's own medical colleges are held to. If Charles University's First Faculty of Medicine publishes that data and it shows its international cohort performs on par with domestic students, this investigation closes in the institution's favour. If it shows a gap, Indian families deserve to know before they sign the enrolment contract.
The accreditors have spoken. The faculty has not. The data does not exist. That is the story, and it is sufficient reason for New Delhi to stop treating the 25,000 as a private choice and start treating them as a policy responsibility.
If you are an enrolled or former student at Charles University's First Faculty of Medicine with direct knowledge of examination practices or student-support structures, this column welcomes contact on record or background.
